Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Nasopharyngeal Carcinoma (NPC)
Clinical trial register · China

Nasopharyngeal Carcinoma (NPC) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Guangzhou 17 Nanning 8 Shanghai 4 Wuhan 3 Changsha 3
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou17 Nanning8 Shanghai4 Wuhan3 Changsha3
All 29 locations
Target enrolment
to

Nasopharyngeal Carcinoma (NPC) trials in China

41 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-11-01
Not yet open
Zhongshan People's Hospital, Guangdong, China
Observational
1,500
Zhongshan, Nanning
2026-11-01
Not yet open
Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
NCT07303283Nasopharyngeal Carcinoma (NPC), Locoregionally Advanced Nasopharyngeal Carcinoma, Adjuvant Therapy
Kai Hu
Phase 2
140
Nanning
2026-09-01
Not yet open
Fudan University
Phase 2
269
Shanghai
2026-09-01
Not yet open
Sun Yat-sen University
Phase 2
28
Guangzhou
2026-09-01
Not yet open
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
60
Guangzhou
2026-09
Not yet open
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
30
Chongqing, Guangzhou
2026-09
Not yet open
Impacted Tooth Management and Osteoradionecrosis Risk in NPC
NCT07764887Nasopharyngeal Carcinoma (NPC), Osteoradionecrosis of the Jaw
First Affiliated Hospital of Guangxi Medical University
Not applicable
536
Baise City, Beihai, Guigang, Guilin, Liuzhou, Nanning, Wuzhou, Yulin
2026-08-30
Recruiting
Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma
NCT07819656Nasopharyngeal Carcinoma (NPC), Myelosuppression
Nanfang Hospital, Southern Medical University
Observational
1,782
Guangzhou
2026-08-26
Recruiting
Hongmeng Yu
Phase 2
25
Shanghai
2026-08-01
Not yet open
Sun Yat-sen University
Phase 2
48
Xiamen, Guangzhou, Guilin
2026-08-01
Recruiting
Fudan University
Phase 2
148
Shanghai
2026-08
Recruiting
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
NCT07567742Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 2
130
Guangzhou
2026-05-08
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
651
Beijing
2026-05-01
Recruiting
First Affiliated Hospital of Guangxi Medical University
Phase 3
266
Nanning
2026-03-05
Recruiting
Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma
NCT06796270Nasopharyngeal Carcinoma (NPC)
The Second Affiliated Hospital of Hainan Medical University
Not applicable
24
Haikou
2026-02-20
Not yet open
Sun Yat-sen University
Phase 2
37
Guangzhou
2026-02
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
900
Beijing
2026-01-01
Recruiting
Man Hu
Phase 3
300
Jinan
2025-12-15
Recruiting
Ming-Yuan Chen
Phase 3
456
Guangzhou, Shantou, Zhongshan, Nanning, Wuzhou, Wuhan, Changsha, Guangdong
2025-11-18
Recruiting
Sun Yat-sen University
Phase 2
41
Guangdong
2025-10-17
Recruiting
Jiangxi Provincial Cancer Hospital
Phase 2
23
Nanchang
2025-10-10
Recruiting
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
NCT07303023Nasopharyngeal Carcinoma (NPC)
Fudan University
Phase 3
462
Shanghai, Hangzhou, Chengdu, Chongqing
2025-09-01
Recruiting
Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma
NCT07137052Nasopharyngeal Carcinoma (NPC), PET / CT
The First Affiliated Hospital of Xiamen University
Observational
732
Xiamen
2025-08-30
Recruiting
Ming-Yuan Chen
Phase 3
166
Zhuhai
2025-08-20
Recruiting
Affiliated Hospital of Guangdong Medical University
Phase 2
30
Zhanjiang
2025-07-30
Not yet open
Sun Yat-sen University
Phase 3
664
Guangzhou
2025-05-01
Recruiting
Shanghai Henlius Biotech
Phase 2
70
Fuzhou, Dongguan, Guangzhou, Shenzhen, Nanning, Guiyang, Wuhan, Changsha
2025-04-02
Active, closed
Sun Yat-sen University
Phase 3
466
Fuzhou, Guangzhou, Shenzhen, Zhanjiang, Nanning, Guiyang, Changsha, Chengdu
2025-02-17
Recruiting
Ming-Yuan Chen
Not applicable
68,649
Zhuhai
2025-01-24
Recruiting
Jiangxi Provincial Cancer Hospital
Phase 2
109
Nanchang
2025-01-01
By invitation
Prognostic Value of TIL in Nasopharyngeal Carcinoma
NCT06763640Nasopharyngeal Carcinoma (NPC)
Jiangxi Provincial Cancer Hospital
Observational
216
Nanchang
2025-01-01
Active, closed
First Affiliated Hospital, Sun Yat-Sen University
Observational
700
Guangzhou
2024-12-25
Recruiting
"Xijiang Project" Screening Cohort for NPC
NCT06787456Nasopharyngeal Carcinoma (NPC), Screening
Ming-Yuan Chen
Observational
1,000,000
Zhuhai
2024-11-14
Not yet open
First Affiliated Hospital of Guangxi Medical University
Phase 2
150
Nanning
2024-11
Recruiting
Sun Yat-sen University
Phase 1
24
Guangzhou
2024-08-02
Active, closed
Hubei Cancer Hospital
Observational
60
Wuhan
2023-04-01
Recruiting
Affiliated Hospital of Guangdong Medical University
Phase 3
180
Zhanjiang
2022-08-15
Rows per page Showing 1–41 of 41
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-china/condition/nasopharyngeal-carcinoma-npc

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 41 of those studies listing the condition Nasopharyngeal Carcinoma (NPC).

How many Nasopharyngeal Carcinoma (NPC) trials are recruiting in China?

23 of the 41 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 14 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nasopharyngeal Carcinoma (NPC)), 41 studies
PhaseStudiesRecruitingShare
Phase 216839%
Phase 311826.8%
Observational8419.5%
Not applicable429.8%
Phase 1112.4%
Phase 1/2102.4%

Most active sponsors

Lead sponsors with the most studies (Nasopharyngeal Carcinoma (NPC))
Lead sponsorStudiesRecruiting
Sun Yat-sen University104
Ming-Yuan Chen44
First Affiliated Hospital of Guangxi Medical University31
Fudan University32
Jiangxi Provincial Cancer Hospital32
Sichuan Baili Pharmaceutical Co., Ltd.30
Affiliated Hospital of Guangdong Medical University22
Cancer Institute and Hospital, Chinese Academy of Medical Sciences22
First Affiliated Hospital, Sun Yat-Sen University10
Guangzhou Concord Cancer Center10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.